Enact Holdings Inc
11 nominees · 3 ballot items.
Election of eleven directors; advisory (non-binding) vote to approve named executive officer compensation (say-on-pay); ratification of KPMG LLP as independent registered public accounting firm for 2026.
Follow how the vote landed and what changed on Enact Holdings Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect eleven nominees named in the proxy statement to hold office until the 2027 annual meeting.
- 2
Advisory Vote to Approve Named Executive Officer Compensation
ManagementBoard: FORNon-binding advisory vote to approve the compensation of the named executive officers as disclosed in the proxy statement.
- 3
Ratification of Selection of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify the Audit Committee’s selection of KPMG LLP as Enact’s independent registered public accounting firm for 2026.
Nominees on the ballot11
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 2.2% | 3,044,545 | $124M |
| 2 | DIMENSIONAL FUND ADVISORS LP | 2.0% | 2,838,327 | $116M |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.2% | 1,740,973 | $71M |
| 4 | FIRST TRUST ADVISORS LP | 1.0% | 1,391,085 | $57M |
| 5 | Glendon Capital Management LP | 0.9% | 1,298,718 | $53M |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 0.9% | 1,295,642 | $53M |
| 7 | STATE STREET CORP | 0.9% | 1,206,061 | $49M |
| 8 | BlackRock, Inc. | 0.8% | 1,063,988 | $43M |
| 9 | LSV ASSET MANAGEMENT | 0.7% | 1,025,564 | $42M |
| 10 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.7% | 992,987 | $41M |
Other Financial Services sector meetings6
Upcoming shareholder meetings at Enact Holdings Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Enact Holdings Inc 2026 annual meeting?
- Enact Holdings Inc (ACT) holds its 2026 annual shareholder meeting on Wednesday, May 13, 2026.
- What is the record date for the Enact Holdings Inc 2026 meeting?
- The record date for the Enact Holdings Inc 2026 meeting is Monday, March 16, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Enact Holdings Inc's 2026 meeting?
- The board is presenting 11 director nominees at the Enact Holdings Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Enact Holdings Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Enact Holdings Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.